D-0074-2025 Class II Ongoing
FDA drug recall D-0074-2025 was initiated by Neogen Corporation on Oct 8, 2024 and is designated Class II. Reason for recall: CGMP violations. The recall status is ongoing. Affected quantity: 8,328 jugs.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 4, 2024
- Initiation Date
- Oct 8, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,328 jugs
Product description
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53247-124-02
Reason for recall
CGMP violations.
Distribution pattern
Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.
Code information
Lot, expiry: LO09530, exp 11/3/2024; LO13412, exp 12/7/2024; LO10263, exp 1/26/2025; LO11303, exp 5/10/2025; LO12153, exp 8/3/2025; LO12483, exp 9/5/2025; LO13183, exp 11/14/2025; LO106024, exp 2/29/2026; LO108624, exp 3/26/2026; LO110224, exp 4/11/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0074-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026